The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...
Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
News Medical on MSN6h
Unfolded protein response: A key regulator of intestinal health and diseaseThe intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...
Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) ...
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and ...
Gut health is about how well your body digests food, absorbs nutrients, and maintains a balance of good and bad bacteria.
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...
As fires rage in California, more information is coming out air pollution's risk for serious health problems. High levels of fine particles in smoke, burning coal, and from road traffic, called PM2.5 ...
A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback